Annex 1 Compliance in Sterile Manufacturing
International pharmaceutical company for sterile products
An international pharmaceutical company specializing in sterile products had to align its processes and systems with the new requirements of Annex 1 of the EU GMP Guidelines.
The challenge
The situation
The pharmaceutical company faced the stringent requirements of Annex 1 of the EU GMP Guidelines, which called for far-reaching adjustments to its existing processes and systems. The focus was on tighter contamination controls, facility modifications, enhanced risk management, as well as expanded documentation and continuous monitoring.
Our approach
What we delivered
Conducting a gap analysis to compare the current state against the target state defined by the Annex 1 requirements
Implementing new, digital monitoring systems for continuous control
Optimizing the manufacturing processes for sterile production
Developing training programs for the staff involved
The outcome
Results & impact
-30% contamination risk
Reduction of contamination risk by 30 percent through the new monitoring systems.
Compliance ahead of deadline
Annex 1 compliance achieved before the regulatory deadline.
More efficient operations
More efficient manufacturing operations in sterile production.
In summary
Annex 1 compliance was successfully implemented and achieved ahead of the regulatory deadline. As a result, the pharmaceutical company increased the safety of its sterile manufacturing.
Regulations & standards considered
- EU GMP Annex 1 (sterile manufacturing)
Related expertise
Annex 1 (Sterile Manufacturing) →
Regulatory framework for sterile manufacturing in accordance with EU GMP Annex 1.
Good Manufacturing Practice (GMP) →
Aligning processes and facilities with the EU GMP requirements.
Cleanroom Qualification and Management →
Contamination control and facility modifications in sterile manufacturing.
Risk Management →
Enhanced risk management and continuous monitoring in accordance with Annex 1.
Similar projects
More on Pharma →
Sources
- https://theentourage.de/case-study/annex-1-compliance-sterilproduktion/ (live case study, accessed 2026-06-14)
Your project
A comparable project?
Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.
Prefer direct? +41 61 271 23 80
info@theentourage.ch
- Reply usually within one working day
- 4 offices: DE · CH · IT · US
- 100% life sciences